INSIGHTS
May 13, 2019

When an app store isn’t enough

Consumer genomics startups are finding that it’s tough to build a large-scale consumer business on top of gene sequencers. One explanation? The information just isn’t that useful for most people. In response, companies are shifting their focus to partner with providers who can turn DNA test results into action. (One researcher’s journey makes the case for such an approach—and raises concerns of overtreatment.)

News from us! We’re proud to announce our investment in Podimetrics, a care management company on a mission to help prevent diabetic foot ulcers. Learn more about how their solution tremendously impacts patients and providers alike.

Headlines

Why Amazon Bought PillPack For Nearly $1B—And What’s Next
A deep dive into the startup’s prescription drug journey CNBC | (Tweet)

Feds Want To Show You Health Care Costs On Your Phone
But it could take two years or more to become reality Kaiser Health News | (Tweet)

How Best Buy Is Expanding Its Connection To Seniors
The retailer has a whole division dedicated to its health strategy Star Tribune | (Tweet)

uBiome’s Problems Extended Beyond Billing Tactics
An inside look reveals corners were cut on the science, too Business Insider | (Tweet)

Cyberattacks Prompt Hospitals To Push Device Makers On Security
No security features, no deal The Wall Street Journal | (Tweet)

NIH’s All Of Us Celebrates One Year With Public Launch Of Data
Users can peruse summary stats of the growing database MobiHealthNews | (Tweet)

Practice Fusion Hit With Subpoena Over HIPAA, Kickback Issues
Legal troubles for EHR vendors continue Modern Healthcare | (Tweet)

As Digital Health Moves Forward, Who’s Being Left Out?
Wildflower Health is one company serving the Medicaid population MobiHealthNews | (Tweet)

Recent Funding